Neural circuit adaptations during drug withdrawal — Spotlight on the lateral habenula

Pharmacology Biochemistry and Behavior

Volumn 162, Issue , 2017, Pages 87-93

  Meye, Frank J ^a   Trusel, Massimo ^b,c   Soiza Reilly, Mariano ^c   Mameli, Manuel ^b,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c INSTITUT DU FER À MOULIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; OPIATE;

ADAPTATION; BRAIN NERVE CELL; CLINICAL FEATURE; COCAINE DEPENDENCE; CONNECTOME; DRUG WITHDRAWAL; HABENULA; HUMAN; HYPERACTIVITY; MESOLIMBIC DOPAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RELAPSE; REVIEW; REWARD; STRESS; SYNAPTIC POTENTIAL; ADDICTION; ANIMAL; METABOLISM; NERVE CELL NETWORK; PHYSIOLOGY; PSYCHOLOGY; WITHDRAWAL SYNDROME;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BEHAVIOR, ADDICTIVE; HABENULA; HUMANS; NERVE NET; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 85028295976     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2017.08.007     Document Type: Review

References (105)

1. Ahmed, S.H., Kenny, P.J., Koob, G.F., Markou, A., Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat. Neurosci. 5 (2002), 625–626.
2. Anraku, T., Ikegaya, Y., Matsuki, N., Nishiyama, N., Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test. Psychopharmacology 157 (2001), 217–220.
3. Baiamonte, B.A., Valenza, M., Roltsch, E.A., Whitaker, A.M., Baynes, B.B., Sabino, V., Gilpin, N.W., Nicotine dependence produces hyperalgesia: role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA). Neuropharmacology 77 (2014), 217–223.
4. Barr, A.M., Markou, A., Phillips, A.G., A ‘crash’ course on psychostimulant withdrawal as a model of depression. Trends Pharmacol. Sci. 23 (2002), 475–482.
5. Bonci, A., Williams, J.T., Increased probability of GABA release during withdrawal from morphine. J. Neurosci. 17 (1997), 796–803.
6. Boudreau, A.C., Reimers, J.M., Milovanovic, M., Wolf, M.E., Cell surface AMPA receptors in the rat nucleus accumbens increase during cocaine withdrawal but internalize after cocaine challenge in association with altered activation of mitogen-activated protein kinases. J. Neurosci. 27 (2007), 10621–10635.
7. Breese, G.R., Chu, K., Dayas, C.V., Funk, D., Knapp, D.J., Koob, G.F., Lê D.A., O'Dell, L.E., Overstreet, D.H., Roberts, A.J., Sinha, R., Valdez, G.R., Weiss, F., Stress enhancement of craving during sobriety: a risk for relapse. Alcohol. Clin. Exp. Res. 29 (2005), 185–195.
8. Bruijnzeel, A.W., Prado, M., Isaac, S., Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol. Psychiatry 66 (2009), 110–117.
9. Bruijnzeel, A.W., Ford, J., Rogers, J.A., Scheick, S., Ji, Y., Bishnoi, M., Alexander, J.C., Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats. Pharmacol. Biochem. Behav. 101 (2012), 62–68.
10. Castagné V., Moser, P., Roux, S., and Porsolt, R. D. (2011). Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci. Chapter 8, Unit 8.10A.
11. Chen, B.T., Bowers, M.S., Martin, M., Hopf, F.W., Guillory, A.M., Carelli, R.M., Chou, J.K., Bonci, A., Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron 59 (2008), 288–297.
12. Conrad, K.L., Tseng, K.Y., Uejima, J.L., Reimers, J.M., Heng, L.J., Shaham, Y., Marinelli, M., Wolf, M.E., Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454 (2008), 118–121.
13. Creed, M., Pascoli, V.J., Lüscher, C., Addiction therapy. Refining deep brain stimulation to emulate optogenetic treatment of synaptic pathology. Science 347 (2015), 659–664.
14. Creed, M., Ntamati, N.R., Chandra, R., Lobo, M.K., Lüscher, C., Convergence of reinforcing and anhedonic cocaine effects in the ventral pallidum. Neuron 92 (2016), 214–226.
15. Crowley, N.A., Bloodgood, D.W., Hardaway, J.A., Kendra, A.M., McCall, J.G., Al-Hasani, R., McCall, N.M., Yu, W., Schools, Z.L., Krashes, M.J., Lowell, B.B., Whistler, J.L., Bruchas, M.R., Kash, T.L., Dynorphin controls the gain of an amygdalar anxiety circuit. Cell Rep. 14 (2016), 2774–2783.
16. Cryan, J.F., Hoyer, D., Markou, A., Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol. Psychiatry 54 (2003), 49–58.
17. Di Chiara, G., Imperato, A., Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85 (1988), 5274–5278.
18. Diana, M., Pistis, M., Muntoni, A., Gessa, G., Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther. 272 (1995), 781–785.
19. Diana, M., Muntoni, A.L., Pistis, M., Melis, M., Gessa, G.L., Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur. J. Neurosci. 11 (1999), 1037–1041.
20. Espejo, E.F., Serrano, M.I., Caillé S., Stinus, L., Behavioral expression of opiate withdrawal is altered after prefrontocortical dopamine depletion in rats: monoaminergic correlates. Neuropsychopharmacology 25 (2001), 204–212.
21. Ettenberg, A., Raven, M.A., Danluck, D.A., Necessary, B.D., Evidence for opponent-process actions of intravenous cocaine. Pharmacol. Biochem. Behav. 64 (1999), 507–512.
22. Everitt, B.J., Robbins, T.W., Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8 (2005), 1481–1489.
23. Friedman, A., Lax, E., Dikshtein, Y., Abraham, L., Flaumenhaft, Y., Sudai, E., Ben-Tzion, M., Ami-Ad, L., Yaka, R., Yadid, G., Electrical stimulation of the lateral habenula produces enduring inhibitory effect on cocaine seeking behavior. Neuropharmacology 59 (2010), 452–459.
24. Garfield, J.B., Lubman, D.I., Yücel, M., Anhedonia in substance use disorders: a systematic review of its nature, course and clinical correlates. Aust. N. Z. J. Psychiatry 48 (2014), 36–51.
25. Gawin, F., Kleber, H., Pharmacologic treatments of cocaine abuse. Psychiatr. Clin. North Am. 9 (1986), 573–583.
26. Georges, F., Le Moine, C., Aston-Jones, G., No effect of morphine on ventral tegmental dopamine neurons during withdrawal. J. Neurosci. 26 (2006), 5720–5726.
27. Gill, M.J., Ghee, S.M., Harper, S.M., See, R.E., Inactivation of the lateral habenula reduces anxiogenic behavior and cocaine seeking under conditions of heightened stress. Pharmacol. Biochem. Behav. 111 (2013), 24–29.
28. Girault, J.A., Greengard, P., The neurobiology of dopamine signaling. Arch. Neurol. 61 (2004), 641–644.
29. Hatzigiakoumis, D.S., Martinotti, G., Giannantonio, M.D., Janiri, L., Anhedonia and substance dependence: clinical correlates and treatment options. Front. Psych., 2, 2011, 10.
30. Hearing, M.C., Jedynak, J., Ebner, S.R., Ingebretson, A., Asp, A.J., Fischer, R.A., Schmidt, C., Larson, E.B., Thomas, M.J., Reversal of morphine-induced cell-type-specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 757–762.
31. Hikosaka, O., The habenula: from stress evasion to value-based decision-making. Nat. Rev. Neurosci. 11 (2010), 503–513.
32. Hirani, K., Khisti, R.T., Chopde, C.T., Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one. Neuropharmacology 43 (2002), 1339–1350.
33. Hong, S., Hikosaka, O., The globus pallidus sends reward-related signals to the lateral habenula. Neuron 60 (2008), 720–729.
34. Imperato, A., Mele, A., Scrocco, M.G., Puglisi-Allegra, S., Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction. Eur. J. Pharmacol. 212 (1992), 299–300.
35. Jhou, T.C., Good, C.H., Rowley, C.S., Xu, S.P., Wang, H., Burnham, N.W., Hoffman, A.F., Lupica, C.R., Ikemoto, S., Cocaine drives aversive conditioning via delayed activation of dopamine-responsive habenular and midbrain pathways. J. Neurosci. 33 (2013), 7501–7512.
36. Kalivas, P.W., Duffy, P., Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13 (1993), 266–275.
37. Kasanetz, F., Deroche-Gamonet, V., Berson, N., Balado, E., Lafourcade, M., Manzoni, O., Piazza, P.V., Transition to addiction is associated with a persistent impairment in synaptic plasticity. Science 328 (2010), 1709–1712.
38. Kelsey, J.E., Verhaak, A.M., Schierberl, K.C., The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats. Behav. Brain Res. 283 (2015), 16–21.
39. Kenny, P.J., Markou, A., Neurobiology of the nicotine withdrawal syndrome. Pharmacol. Biochem. Behav. 70 (2001), 531–549.
40. Kenny, P.J., Markou, A., Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31 (2006), 1203–1211.
41. Koob, G.F., Le Moal, M., Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001), 97–129.
42. Koob, G.F., Volkow, N.D., Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3 (2016), 760–773.
43. Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., and George, O. (2014). Addiction as a stress surfeit disorder. Neuropharmacology 76 Pt B, 370–382.
44. Kosten, T.R., O'Connor, P.G., Management of drug and alcohol withdrawal. N. Engl. J. Med. 348 (2003), 1786–1795.
45. Kourrich, S., Rothwell, P.E., Klug, J.R., Thomas, M.J., Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens. J. Neurosci. 27 (2007), 7921–7928.
46. Kravitz, A.V., Tomasi, D., LeBlanc, K.H., Baler, R., Volkow, N.D., Bonci, A., Ferré S., Cortico-striatal circuits: novel therapeutic targets for substance use disorders. Brain Res. 1628 (2015), 186–198.
47. Lammel, S., Lim, B.K., Ran, C., Huang, K.W., Betley, M.J., Tye, K.M., Deisseroth, K., Malenka, R.C., Input-specific control of reward and aversion in the ventral tegmental area. Nature 491 (2012), 212–217.
48. Lammel, S., Steinberg, E.E., Földy, C., Wall, N.R., Beier, K., Luo, L., Malenka, R.C., Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons. Neuron 85 (2015), 429–438.
49. Lecca, S., Meye, F.J., Mameli, M., The lateral habenula in addiction and depression: an anatomical, synaptic and behavioral overview. Eur. J. Neurosci. 39 (2014), 1170–1178.
50. Lecca, S., Pelosi, A., Tchenio, A., Moutkine, I., Lujan, R., Hervé D., Mameli, M., Rescue of GABAB and GIRK function in the lateral habenula by protein phosphatase 2A inhibition ameliorates depression-like phenotypes in mice. Nat. Med. 22 (2016), 254–261.
51. Li, B., Piriz, J., Mirrione, M., Chung, C., Proulx, C.D., Schulz, D., Henn, F., Malinow, R., Synaptic potentiation onto habenula neurons in the learned helplessness model of depression. Nature 470 (2011), 535–539.
52. Logrip, M.L., Koob, G.F., Zorrilla, E.P., Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. CNS Drugs 25 (2011), 271–287.
53. Lüscher, C., Ungless, M.A., The mechanistic classification of addictive drugs. PLoS Med., 3, 2006, e437.
54. MacAskill, A.F., Cassel, J.M., Carter, A.G., Cocaine exposure reorganizes cell type- and input-specific connectivity in the nucleus accumbens. Nat. Neurosci. 17 (2014), 1198–1207.
55. Madhavan, A., Bonci, A., Whistler, J.L., Opioid-induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area. J. Neurosci. 30 (2010), 14029–14035.
56. Mague, S.D., Pliakas, A.M., Todtenkopf, M.S., Tomasiewicz, H.C., Zhang, Y., Stevens, W.C., Jones, R.M., Portoghese, P.S., Carlezon, W.A., Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J. Pharmacol. Exp. Ther. 305 (2003), 323–330.
57. Mameli, M., Halbout, B., Creton, C., Engblom, D., Parkitna, J.R., Spanagel, R., Lüscher, C., Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. Nat. Neurosci. 12 (2009), 1036–1041.
58. Mantsch, J.R., Baker, D.A., Funk, D., Lê A.D., Shaham, Y., Stress-induced reinstatement of drug seeking: 20 years of progress. Neuropsychopharmacology 41 (2016), 335–356.
59. Margolis, E.B., Fields, H.L., Mu opioid receptor actions in the lateral habenula. PLoS One, 11, 2016, e0159097.
60. Maroteaux, M., Mameli, M., Cocaine evokes projection-specific synaptic plasticity of lateral habenula neurons. J. Neurosci. 32 (2012), 12641–12646.
61. Matsumoto, M., Hikosaka, O., Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 447 (2007), 1111–1115.
62. Meshul, C.K., Noguchi, K., Emre, N., Ellison, G., Cocaine-induced changes in glutamate and GABA immunolabeling within rat habenula and nucleus accumbens. Synapse 30 (1998), 211–220.
63. Meye, F.J., van Zessen, R., Smidt, M.P., Adan, R.A., Ramakers, G.M., Morphine withdrawal enhances constitutive μ-opioid receptor activity in the ventral tegmental area. J. Neurosci. 32 (2012), 16120–16128.
64. Meye, F.J., Valentinova, K., Lecca, S., Marion-Poll, L., Maroteaux, M.J., Musardo, S., Moutkine, I., Gardoni, F., Huganir, R.L., Georges, F., Mameli, M., Cocaine-evoked negative symptoms require AMPA receptor trafficking in the lateral habenula. Nat. Neurosci. 18 (2015), 376–378.
65. Meye, F.J., Soiza-Reilly, M., Smit, T., Diana, M.A., Schwarz, M.K., Mameli, M., Shifted pallidal co-release of GABA and glutamate in habenula drives cocaine withdrawal and relapse. Nat. Neurosci. 19 (2016), 1019–1024.
66. Morris, J.S., Smith, K.A., Cowen, P.J., Friston, K.J., Dolan, R.J., Covariation of activity in habenula and dorsal raphé nuclei following tryptophan depletion. NeuroImage 10 (1999), 163–172.
67. Muschamp, J.W., Carlezon, W.A., Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation. Cold Spring Harb. Perspect. Med., 3, 2013, a012005.
68. Neisewander, J.L., Lucki, I., McGonigle, P., Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats. Synapse 16 (1994), 1–10.
69. Neumann, P.A., Ishikawa, M., Otaka, M., Huang, Y.H., Schlüter, O.M., Dong, Y., Increased excitability of lateral habenula neurons in adolescent rats following cocaine self-administration. Int. J. Neuropsychopharmacol., 2014, 18.
70. O'Brien, C.P., Review. Evidence-based treatments of addiction. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 363 (2008), 3277–3286.
71. Pascoli, V., Turiault, M., Lüscher, C., Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour. Nature 481 (2011), 71–75.
72. Pascoli, V., Terrier, J., Espallergues, J., Valjent, E., O'Connor, E.C., Lüscher, C., Contrasting forms of cocaine-evoked plasticity control components of relapse. Nature 509 (2014), 459–464.
73. Piazza, P.V., Le Moal, M.L., Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 36 (1996), 359–378.
74. Pickens, C.L., Airavaara, M., Theberge, F., Fanous, S., Hope, B.T., Shaham, Y., Neurobiology of the incubation of drug craving. Trends Neurosci. 34 (2011), 411–420.
75. Pliakas, A.M., Carlson, R.R., Neve, R.L., Konradi, C., Nestler, E.J., Carlezon, W.A., Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 21 (2001), 7397–7403.
76. Puig, S., Noble, F., Benturquia, N., Short- and long-lasting behavioral and neurochemical adaptations: relationship with patterns of cocaine administration and expectation of drug effects in rats. Transl. Psychiatry, 2, 2012, e175.
77. Qi, X., Shan, Z., Ji, Y., Guerra, V., Alexander, J.C., Ormerod, B.K., Bruijnzeel, A.W., Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal. Transl. Psychiatry, 4, 2014, e385.
78. Robertson, M.W., Leslie, C.A., Bennett, J.P., Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res. 538 (1991), 337–339.
79. Robinson, T.E., Jurson, P.A., Bennett, J.A., Bentgen, K.M., Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462 (1988), 211–222.
80. Roni, M.A., Rahman, S., The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice. Psychopharmacology 231 (2014), 2989–2998.
81. Root, D.H., Hoffman, A.F., Good, C.H., Zhang, S., Gigante, E., Lupica, C.R., Morales, M., Norepinephrine activates dopamine D4 receptors in the rat lateral habenula. J. Neurosci. 35 (2015), 3460–3469.
82. Russell, S.E., Puttick, D.J., Sawyer, A.M., Potter, D.N., Mague, S., Carlezon, W.A., Chartoff, E.H., Nucleus accumbens AMPA receptors are necessary for morphine-withdrawal-induced negative-affective states in rats. J. Neurosci. 36 (2016), 5748–5762.
83. Sartorius, A., Kiening, K.L., Kirsch, P., von Gall, C.C., Haberkorn, U., Unterberg, A.W., Henn, F.A., Meyer-Lindenberg, A., Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol. Psychiatry 67 (2010), e9–e11.
84. Sasaki, K., Suda, H., Watanabe, H., Yagi, H., Involvement of the entopeduncular nucleus and the habenula in methamphetamine-induced inhibition of dopamine neurons in the substantia nigra of rats. Brain Res. Bull. 25 (1990), 121–127.
85. Schank, J.R., Goldstein, A.L., Rowe, K.E., King, C.E., Marusich, J.A., Wiley, J.L., Carroll, F.I., Thorsell, A., Heilig, M., The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety. Addict. Biol. 17 (2012), 634–647.
86. Schuckit, M.A., Treatment of opioid-use disorders. N. Engl. J. Med. 375 (2016), 1596–1597.
87. Schulteis, G., Koob, G., Neuropharmacology. Dark side of drug dependence. Nature 371 (1994), 108–109.
88. Sepulveda, M.J., Hernandez, L., Rada, P., Tucci, S., Contreras, E., Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study. Pharmacol. Biochem. Behav. 60 (1998), 255–262.
89. Shabel, S.J., Proulx, C.D., Trias, A., Murphy, R.T., Malinow, R., Input to the lateral habenula from the basal ganglia is excitatory, aversive, and suppressed by serotonin. Neuron 74 (2012), 475–481.
90. Shaham, Y., Shalev, U., Lu, L., De Wit, H., Stewart, J., The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168 (2003), 3–20.
91. Shippenberg, T.S., Zapata, A., Chefer, V.I., Dynorphin and the pathophysiology of drug addiction. Pharmacol. Ther. 116 (2007), 306–321.
92. Sinha, R., The role of stress in addiction relapse. Curr. Psychiatry Rep. 9 (2007), 388–395.
93. Stamatakis, A.M., Stuber, G.D., Activation of lateral habenula inputs to the ventral midbrain promotes behavioral avoidance. Nat. Neurosci. 15 (2012), 1105–1107.
94. Stamatakis, A.M., Jennings, J.H., Ung, R.L., Blair, G.A., Weinberg, R.J., Neve, R.L., Boyce, F., Mattis, J., Ramakrishnan, C., Deisseroth, K., Stuber, G.D., A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward. Neuron 80 (2013), 1039–1053.
95. Stephenson-Jones, M., Yu, K., Ahrens, S., Tucciarone, J.M., van Huijstee, A.N., Mejia, L.A., Penzo, M.A., Tai, L.H., Wilbrecht, L., Li, B., A basal ganglia circuit for evaluating action outcomes. Nature 539 (2016), 289–293.
96. Ungless, M.A., Whistler, J.L., Malenka, R.C., Bonci, A., Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411 (2001), 583–587.
97. Volkow, N.D., Koob, G., Brain disease model of addiction: why is it so controversial. Lancet Psychiatry 2 (2015), 677–679.
98. Volkow, N.D., Wang, G.J., Fowler, J.S., Imaging studies of cocaine in the human brain and studies of the cocaine addict. Ann. N. Y. Acad. Sci. 820 (1997), 41–54 (discussion 54).
99. Wang, L., Tu, P., Bonet, L., Aubrey, K.R., Supplisson, S., Cytosolic transmitter concentration regulates vesicle cycling at hippocampal GABAergic terminals. Neuron 80 (2013), 143–158.
100. Wee, S., Koob, G.F., The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 210 (2010), 121–135.
101. West, R., Gossop, M., Overview: a comparison of withdrawal symptoms from different drug classes. Addiction 89 (1994), 1483–1489.
102. Wolf, M.E., Ferrario, C.R., AMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine. Neurosci. Biobehav. Rev. 35 (2010), 185–211.
103. Zapata, A., Hwang, E.K., Lupica, C.R., Lateral habenula involvement in impulsive cocaine seeking. Neuropsychopharmacology, 2017.
104. Zhang, C.X., Zhang, H., Xu, H.Y., Li, M.X., Wang, S., The lateral habenula is a common target of cocaine and dexamethasone. Neurosci. Lett. 555 (2013), 12–17.
105. Zorrilla, E.P., Logrip, M.L., Koob, G.F., Corticotropin releasing factor: a key role in the neurobiology of addiction. Front. Neuroendocrinol. 35 (2014), 234–244.